Featured Research

from universities, journals, and other organizations

Studies reveal substantial increases in non-melanoma skin cancers

Date:
March 16, 2010
Source:
JAMA and Archives Journals
Summary:
Both new diagnoses and a history of non-melanoma skin cancer appear to have become increasingly common, and the disease affects more individuals than all other cancers combined, according to two new reports.

Both new diagnoses and a history of non-melanoma skin cancer appear to have become increasingly common, and the disease affects more individuals than all other cancers combined, according to two reports in the March issue of Archives of Dermatology.

The article is one of several in the issue focusing on skin cancers, and is being published in conjunction with a JAMA theme issue on cancer. The March issues of Archives of Pediatrics & Adolescent Medicine, Archives of Neurology, Archives of Internal Medicine, Archives of Ophthalmology, Archives of Surgery, Archives of Facial Plastic Surgery and Archives of Otolaryngology-Head & Neck Surgery will also publish articles on this topic.

Non-melanoma skin cancer is the most common malignant disease in the United States, according to background information in one of the articles. The disease is associated with substantial illness and cost, and a death rate that is lower than other cancers but still significant. However, non-melanoma skin cancer is not typically reported to cancer registries, and the most recent peer-reviewed, published national estimates date back to 1994. "Understanding skin cancer incidence and treatment is important for planning prevention strategies and allocating resources for treatment," the authors write.

In one article, Robert S. Stern, M.D., of Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, developed a mathematical model to estimate the prevalence of non-melanoma skin cancer in 2007. "This model used age-specific incidence data adjusted to reflect changes in incidence from 1957 to 2006, the age distribution of the population from 1957 to 2006 and the likelihood that an incident tumor was the first ever for that person," Dr. Stern writes.

Based on the model, Dr. Stern estimates that approximately 13 million white, non-Hispanic Americans had had at least one non-melanoma skin cancer by 2007. About one in five 70-year-olds have had non-melanoma skin cancers, and most who were affected have had more than one. "The prevalence of a history of skin cancer is far higher than that of any other cancer and exceeds that of all other cancers diagnosed since 1975," and is about five times higher than that of breast or prostate cancer, he writes.

In another article, Howard W. Rogers, M.D., Ph.D., of Advanced Dermatology, Norwich, Conn., and colleagues analyzed data from two Medicare databases and national surveys to estimate the incidence and treatment rates of non-melanoma skin cancer in 2006.

The total number of procedures to treat skin cancer in the Medicare population increased 76.9 percent from an estimated approximately 1.6 million procedures in 1992 to approximately 2 million procedures in 2006. Between 2002 and 2006, when database linkages allowed more detailed analyses, procedures to treat non-melanoma skin cancer increased 16 percent, the number of procedures per affected person increased 1.5 percent and the number of individuals undergoing at least one procedure increased by 14.3 percent.

Based on the results, the researchers estimate that in 2006 there were more than 3.5 million non-melanoma skin cancers in the United States and that approximately 2.1 million patients were treated for the disease.

"There is an epidemic of non-melanoma skin cancer in the United States, as illustrated by comparison with the previously published estimates and the 4.2 percent yearly average increase in cases in the Medicare population from 1992 to 2006," the authors conclude. "To date, educational programs emphasizing sun protection have mainly been disappointing in slowing skin cancer rates. In the face of ongoing increases in skin cancer incidence, continued national research and programs on treatment, education and prevention are critical."

Other articles featured in this issue include the following:

Melanoma Survivors Appear to Be at Increased Risk for Another Melanoma

Survivors of one melanoma appear approximately nine times as likely as the general population to develop a second melanoma. Porcia T. Bradford, M.D., and colleagues at the National Cancer Institute, Bethesda, Md., used nine cancer registries to identify 89,515 patients who survived at least two months after an initial melanoma diagnosis between 1973 and 2006.

Of these, 10,857 (12.1 percent) developed one or more additional primary cancers, such that their overall risk of another cancer increased by 28 percent. One-fourth of these subsequent cancers were primary melanomas. Women with head and neck melanoma and patients younger than 30 had additionally increased risks of a subsequent melanoma.

"The risk remains elevated more than 20 years after the initial melanoma diagnosis. This increased risk may be owing to behavioral factors, genetic susceptibility or medical surveillance," the authors conclude. "Melanoma survivors should remain under surveillance not only for recurrence but also for future primary melanomas and other cancers."

Older Adults With Melanoma Incur Significant Costs

Treating melanoma in older adults is estimated to cost approximately $249 million annually. Anne M. Seidler, M.D., M.B.A., Emory University School of Medicine, Atlanta, and colleagues used national databases to assess health care resource consumption by a total of 1,858 patients age 65 and older with melanoma during fiscal years 1991 to 1996.

Melanoma-related charges for older patients totaled an estimated $2,200 per month during the first four months of treatment, close to $4,000 monthly during the last six months and about $900 per month in the interim phase. Per patient, lifetime disease-related costs totaled up to $28,210 from the time of diagnosis to the time of death.

"Although relatively few patients actually die of this condition, the per-patient expenditures have particular significance in late-stage disease," the authors write. "The majority of consumption is attributable to advanced-stage disease and the terminal phase of treatment. If all patients were diagnosed and effectively treated in stage 0 or 1, we estimate that the annual direct costs for the population 65 years or older would be between $99 million and $161 million, or 40 percent to 65 percent of their current value of $249 million. Policy guidelines for melanoma screening should consider that patients 65 years or older represent an increased risk, and thus, economic burden, for later-stage melanoma."

Study Identifies Factors Associated With Early Detection of Melanoma

Early detection of melanoma appears more common among younger patients, those living in areas with high concentrations of dermatologists and those whose cancer is detected by dermatologists. Fr้d้rique Durbec, M.D., of H๔pital Robert Debr้, France, and colleagues studied new cases of cutaneous melanoma in five regions of northeastern France in 2004.

Of the 652 patients who had cancers detected, 45.1 percent were diagnosed among those who consulted dermatologists directly, 26.1 percent were referred to dermatologists by general practitioners, 14.1 percent were diagnosed when consulting a dermatologist for another disease and 8.4 percent were diagnosed during a follow-up visit for skin lesions. Patients who were referred to dermatologists were older and had the highest frequency of thick, or more advanced, melanomas, whereas those diagnosed on a follow-up visit had no thick or ulcerated melanomas.

"Easy access of patients to dermatologists, information campaigns targeting elderly people and education of general practitioners are complementary approaches to improving early detection," the authors write.

Special Article: Skin Cancer Should Be Treated as a Chronic Disease

"To manage the future costs and quality of care for patients with skin cancer, a revised health strategy is needed," write Simone van der Geer, M.D., of Erasmus University Medical Center, Rotterdam, and colleagues in a special article. "These new strategies should be combined into a disease management system that organizes health care for one well-documented health care problem using a systematic approach."

"By applying the disease management systems approach, multiple opportunities for chronic skin cancer care become apparent in prevention, education, multidisciplinary care, information technology and management," they continue. "The disease management system is embedded within a supportive overall organization structure, which is based on firm financial support that must be available for all aspects of the system, including prevention-based efforts."

"Skin cancer needs to be regarded as a chronic disease and should not be considered a solitary event requiring the treatment of one tumor," they conclude. "Combining these strategies in a disease management system will lead to efficient, evidence-based, high-quality care to help dermatologists deal proactively with chronic diseases such as skin cancer."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal References:

  1. Robert S. Stern. Prevalence of a History of Skin Cancer in 2007: Results of an Incidence-Based Model. Arch Dermatol, 2010; 146 (3): 279-282 [link]
  2. Howard W. Rogers; Martin A. Weinstock; Ashlynne R. Harris; Michael R. Hinckley; Steven R. Feldman; Alan B. Fleischer; Brett M. Coldiron. Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006. Arch Dermatol, 2010; 146 (3): 283-287 [link]
  3. Porcia T. Bradford; D. Michal Freedman; Alisa M. Goldstein; Margaret A. Tucker. Increased Risk of Second Primary Cancers After a Diagnosis of Melanoma. Arch Dermatol, 2010; 146 (3): 265-272 [link]
  4. Anne M. Seidler; Michelle L. Pennie; Emir Veledar; Steven D. Culler; Suephy C. Chen. Economic Burden of Melanoma in the Elderly Population: Population-Based Analysis of the Surveillance, Epidemiology, and End Results (SEER)-Medicare Data. Arch Dermatol, 2010; 146 (3): 249-256 [link]
  5. Frederique Durbec; Fabien Vitry; Florence Granel-Brocard; Dan Lipsker; Francois Aubin; Guy Hedelin; Sophie Dalac; Francois Truchetet; Catherine Michel; Marie-Laure Batard; Beatrice Domissy-Baury; Jean-Michel Halna; Jean Luc Schmutz; Christian Delvincourt; Georges Reuter; Stephane Dalle; Philippe Bernard; Arlette Danzon; Florent Grange. The Role of Circumstances of Diagnosis and Access to Dermatological Care in Early Diagnosis of Cutaneous Melanoma: A Population-Based Study in France. Arch Dermatol, 2010; 146 (3): 240-246 [link]
  6. Simone van der Geer; Hajo A. Reijers; Harrie F. J. M. van Tuijl; Hein de Vries; Gertruud A. M. Krekels. Need for a New Skin Cancer Management Strategy. Arch Dermatol, 2010; 146 (3): 332-336 [link]

Cite This Page:

JAMA and Archives Journals. "Studies reveal substantial increases in non-melanoma skin cancers." ScienceDaily. ScienceDaily, 16 March 2010. <www.sciencedaily.com/releases/2010/03/100315161726.htm>.
JAMA and Archives Journals. (2010, March 16). Studies reveal substantial increases in non-melanoma skin cancers. ScienceDaily. Retrieved September 3, 2014 from www.sciencedaily.com/releases/2010/03/100315161726.htm
JAMA and Archives Journals. "Studies reveal substantial increases in non-melanoma skin cancers." ScienceDaily. www.sciencedaily.com/releases/2010/03/100315161726.htm (accessed September 3, 2014).

Share This



More Health & Medicine News

Wednesday, September 3, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Snack Attack: Study Says Action Movies Make You Snack More

Snack Attack: Study Says Action Movies Make You Snack More

Newsy (Sep. 2, 2014) — You're more likely to gain weight while watching action flicks than you are watching other types of programming, says a new study published in JAMA. Video provided by Newsy
Powered by NewsLook.com
U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

Newsy (Sep. 2, 2014) — The U.N. says the problem is two-fold — quarantine zones and travel restrictions are limiting the movement of both people and food. Video provided by Newsy
Powered by NewsLook.com
Doctors Fear They're Losing Battle Against Ebola

Doctors Fear They're Losing Battle Against Ebola

AP (Sep. 2, 2014) — As a third American missionary is confirmed to have contracted Ebola in Liberia, doctors on the ground in West Africa fear they're losing the battle against the outbreak. (Sept. 2) Video provided by AP
Powered by NewsLook.com
Tech Giants Bet on 3D Headsets for Gaming, Healthcare

Tech Giants Bet on 3D Headsets for Gaming, Healthcare

AFP (Sep. 2, 2014) — When Facebook acquired the virtual reality hardware developer Oculus VR in March for $2 billion, CEO Mark Zuckerberg hailed the firm's technology as "a new communication platform." Duration: 02:24 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins